Clinical Trial Update: Value of Fecal Calprotectin

View source ↗

Summary

This completed clinical trial evaluated the value of fecal calprotectin as a biomarker in inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: Indiana University | Conditions: Calprotectin, Inflammatory Bowel Disease | Status: COMPLETED